NASDAQ:HJLI - Hancock Jaffe Laboratories News Headlines

Sign in or create an account to add this stock to your watchlist.
$2.40 +0.01 (+0.42 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$2.39
Today's Range$2.32 - $2.49
52-Week Range$1.31 - $5.64
Volume88,953 shs
Average Volume157,688 shs
Market Capitalization$34.00 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Hancock Jaffe Laboratories (NASDAQ HJLI) News Headlines

Source:
DateHeadline
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart InstituteHancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute
www.finanznachrichten.de - March 19 at 10:40 AM
Hancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart InstituteHancock Jaffe Announces Successful Start to CoreoGraft Study at Texas Heart Institute
finance.yahoo.com - March 18 at 11:17 AM
Robert Andrew Berman Acquires 21,740 Shares of Hancock Jaffe Laboratories Inc (HJLI) StockRobert Andrew Berman Acquires 21,740 Shares of Hancock Jaffe Laboratories Inc (HJLI) Stock
www.americanbankingnews.com - March 14 at 8:56 PM
These Four Healthcare Stocks Could Test March HighsThese Four Healthcare Stocks Could Test March Highs
finance.yahoo.com - March 14 at 3:58 PM
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Completes $2.7 Million Private Placement of Common StockHancock Jaffe Laboratories, Inc.: Hancock Jaffe Completes $2.7 Million Private Placement of Common Stock
www.finanznachrichten.de - March 13 at 11:45 AM
Hancock Jaffe Completes $2.7 Million Private Placement of Common StockHancock Jaffe Completes $2.7 Million Private Placement of Common Stock
finance.yahoo.com - March 13 at 11:45 AM
Hancock Jaffe Successfully Starts First-in-Human VenoValve StudyHancock Jaffe Successfully Starts First-in-Human VenoValve Study
finance.yahoo.com - February 19 at 12:24 PM
Hancock Jaffe Announces Objectives for Upcoming CoreoGraft StudyHancock Jaffe Announces Objectives for Upcoming CoreoGraft Study
finance.yahoo.com - January 28 at 11:44 AM
Dr. Marc H. Glickman to Present at 6th Israeli Vascular Access ConferenceDr. Marc H. Glickman to Present at 6th Israeli Vascular Access Conference
finance.yahoo.com - January 15 at 11:05 AM
Hancock Jaffe Announces End Points for First-in-Human VenoValve StudyHancock Jaffe Announces End Points for First-in-Human VenoValve Study
finance.yahoo.com - January 9 at 11:20 AM
Hancock Jaffe Receives Approval for First-in-Human VenoValve StudyHancock Jaffe Receives Approval for First-in-Human VenoValve Study
finance.yahoo.com - December 17 at 10:57 AM
Hancock Jaffe Announces January CoreoGraft Study at the Texas Heart InstituteHancock Jaffe Announces January CoreoGraft Study at the Texas Heart Institute
finance.yahoo.com - December 4 at 10:14 AM
Hancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in ColombiaHancock Jaffe Updates Status of Application to INVIMA for First-In-Human VenoValve Trial in Colombia
finance.yahoo.com - November 20 at 9:39 AM
Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality AssuranceHancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance
finance.yahoo.com - November 13 at 3:25 PM
Hancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart InstituteHancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart Institute
finance.yahoo.com - October 9 at 8:42 AM
Hancock Jaffe Laboratories to Present at The MicroCap Conference on October 2, 2018 in New York CityHancock Jaffe Laboratories to Present at The MicroCap Conference on October 2, 2018 in New York City
finance.yahoo.com - September 28 at 8:19 AM
What Investors Should Know About Hancock Jaffe Laboratories Inc’s (NASDAQ:HJLI) Financial StrengthWhat Investors Should Know About Hancock Jaffe Laboratories Inc’s (NASDAQ:HJLI) Financial Strength
finance.yahoo.com - September 27 at 8:21 AM
Hancock Jaffe Submits Application to INVIMA for First-In-Human VenoValve Trial in ColombiaHancock Jaffe Submits Application to INVIMA for First-In-Human VenoValve Trial in Colombia
finance.yahoo.com - September 24 at 8:12 AM
Diamond Equity Research Initiates Coverage on Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) with a Valuation of $6.60 Per ShareDiamond Equity Research Initiates Coverage on Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) with a Valuation of $6.60 Per Share
finance.yahoo.com - September 20 at 3:20 PM
Hancock Jaffe to Present at Fourth Annual Robins Equity Research Roundup ConferenceHancock Jaffe to Present at Fourth Annual Robins Equity Research Roundup Conference
finance.yahoo.com - September 20 at 7:55 AM
New Study Confirms Significant Potential U.S. Market for Hancock Jaffe’s VenoValve®New Study Confirms Significant Potential U.S. Market for Hancock Jaffe’s VenoValve®
finance.yahoo.com - September 17 at 7:57 AM
Hancock Jaffe Laboratories’ VenoValve Featured in Journal of Vascular Surgery Venous and LymphaticHancock Jaffe Laboratories’ VenoValve Featured in Journal of Vascular Surgery Venous and Lymphatic
www.nasdaq.com - September 12 at 7:43 AM
Hancock Jaffe Laboratories’ VenoValve Featured in Journal of Vascular Surgery Venous and Lymphatic Disorders as a Future Option for Treating Deep Vein DiseaseHancock Jaffe Laboratories’ VenoValve Featured in Journal of Vascular Surgery Venous and Lymphatic Disorders as a Future Option for Treating Deep Vein Disease
finance.yahoo.com - September 12 at 7:43 AM
Hancock Jaffe stock muscles up on new on nod from medical bodyHancock Jaffe stock muscles up on new on nod from medical body
www.baystreet.ca - August 10 at 7:17 AM
Hancock Jaffe Laboratories Receives Medical Research Committee Approval for First-in-Human VenoValve StudyHancock Jaffe Laboratories Receives Medical Research Committee Approval for First-in-Human VenoValve Study
finance.yahoo.com - August 9 at 3:18 PM
Hancock Jaffe Laboratories Receives Ethics Committee Approval for First-in-Human VenoValve StudyHancock Jaffe Laboratories Receives Ethics Committee Approval for First-in-Human VenoValve Study
finance.yahoo.com - July 24 at 8:37 AM
Hancock Jaffe names new CFOHancock Jaffe names new CFO
seekingalpha.com - July 14 at 3:17 PM
Hancock Jaffe Appoints Bob Rankin as Chief Financial OfficerHancock Jaffe Appoints Bob Rankin as Chief Financial Officer
finance.yahoo.com - July 14 at 3:17 PM
Hancock Jaffe Laboratories to Conduct Analysis for FDA Submission Package for Bioprosthetic Heart ValveHancock Jaffe Laboratories to Conduct Analysis for FDA Submission Package for Bioprosthetic Heart Valve
finance.yahoo.com - July 11 at 3:17 PM
Hancock Jaffe Laboratories (HJLI) Says it Selected Site for First-in-Human VenoValve StudyHancock Jaffe Laboratories (HJLI) Says it Selected Site for First-in-Human VenoValve Study
www.streetinsider.com - June 22 at 5:42 AM
Hancock Jaffe Laboratories Selects Site for First-in-Human VenoValve StudyHancock Jaffe Laboratories Selects Site for First-in-Human VenoValve Study
finance.yahoo.com - June 20 at 3:17 PM
Hancock Jaffe Laboratories, Inc. Announces Full Exercise of $1,125,000 Underwriter’s Over AllotmentHancock Jaffe Laboratories, Inc. Announces Full Exercise of $1,125,000 Underwriter’s Over Allotment
finance.yahoo.com - June 12 at 3:15 PM
Hancock Jaffe Laboratories (HJLI) Stock: A Flagship Product That Should Not Be Ignored!Hancock Jaffe Laboratories (HJLI) Stock: A Flagship Product That Should Not Be Ignored!
finance.yahoo.com - June 7 at 8:51 AM
IPO News: 4 IPOs This Week Seeking $827 Million - 24/7 Wall St.IPO News: 4 IPOs This Week Seeking $827 Million - 24/7 Wall St.
247wallst.com - December 19 at 8:40 AM
IPO News: 4 IPOs This Week Seeking $827 MillionIPO News: 4 IPOs This Week Seeking $827 Million
www.msn.com - December 18 at 6:08 PM
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel